Evidence map›Paper›PMID 37486129›Full record

ArticleJournal of visualized experiments : JoVE2023

Tracking Tumor Cell Dissemination from Lung Metastases Using Photoconversion.

Madeline Friedman-DeLuca, Prachiben P Patel, Burcu Karadal-Ferrena, Nicole D Barth, Camille L Duran, Xianjun Ye, Michael Papanicolaou, John S Condeelis, Maja H Oktay, Lucia Borriello and 1 more

Open access · greenAbstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 60% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Madeline Friedman-DeLucaDepartment of Pathology, Albert Einstein College of Medicine/Montefiore Medical Center; Cancer Dormancy and Tumor Microenvironment Institute, Albert Einstein College of Medicine/Montefiore Medical Center.
Prachiben P PatelDepartment of Pathology, Albert Einstein College of Medicine/Montefiore Medical Center; Cancer Dormancy and Tumor Microenvironment Institute, Albert Einstein College of Medicine/Montefiore Medical Center.
Burcu Karadal-FerrenaDepartment of Pathology, Albert Einstein College of Medicine/Montefiore Medical Center; Cancer Dormancy and Tumor Microenvironment Institute, Albert Einstein College of Medicine/Montefiore Medical Center.
Nicole D BarthDepartment of Pathology, Albert Einstein College of Medicine/Montefiore Medical Center; Cancer Dormancy and Tumor Microenvironment Institute, Albert Einstein College of Medicine/Montefiore Medical Center.
Camille L DuranDepartment of Pathology, Albert Einstein College of Medicine/Montefiore Medical Center; Cancer Dormancy and Tumor Microenvironment Institute, Albert Einstein College of Medicine/Montefiore Medical Center.
Xianjun YeDepartment of Pathology, Albert Einstein College of Medicine/Montefiore Medical Center; Cancer Dormancy and Tumor Microenvironment Institute, Albert Einstein College of Medicine/Montefiore Medical Center; Gruss-Lipper Biophotonics Center, Albert Einstein College of Medicine/Montefiore Medical Center.
Michael PapanicolaouCancer Dormancy and Tumor Microenvironment Institute, Albert Einstein College of Medicine/Montefiore Medical Center; Department of Cell Biology, Albert Einstein College of Medicine/Montefiore Medical Center.
John S CondeelisCancer Dormancy and Tumor Microenvironment Institute, Albert Einstein College of Medicine/Montefiore Medical Center; Gruss-Lipper Biophotonics Center, Albert Einstein College of Medicine/Montefiore Medical Center; Department of Cell Biology, Albert Einstein College of Medicine/Montefiore Medical Center; Montefiore Einstein Cancer Center, Albert Einstein College of Medicine/Montefiore Medical Center; Integrated Imaging Program for Cancer Research, Albert Einstein College of Medicine/Montefiore Medical Center; Department of Surgery, Albert Einstein College of Medicine/Montefiore Medical Center.
Maja H OktayDepartment of Pathology, Albert Einstein College of Medicine/Montefiore Medical Center; Cancer Dormancy and Tumor Microenvironment Institute, Albert Einstein College of Medicine/Montefiore Medical Center; Gruss-Lipper Biophotonics Center, Albert Einstein College of Medicine/Montefiore Medical Center; Montefiore Einstein Cancer Center, Albert Einstein College of Medicine/Montefiore Medical Center; Integrated Imaging Program for Cancer Research, Albert Einstein College of Medicine/Montefiore Medical Center; Department of Surgery, Albert Einstein College of Medicine/Montefiore Medical Center.
Lucia Borriello *Department of Pathology, Albert Einstein College of Medicine/Montefiore Medical Center; Cancer Dormancy and Tumor Microenvironment Institute, Albert Einstein College of Medicine/Montefiore Medical Center; Department of Cancer and Cellular Biology, Lewis Katz School of Medicine, Fox Chase Cancer Center; lucia.borriello@temple.edu.
David Entenberg *Department of Pathology, Albert Einstein College of Medicine/Montefiore Medical Center; Cancer Dormancy and Tumor Microenvironment Institute, Albert Einstein College of Medicine/Montefiore Medical Center; Gruss-Lipper Biophotonics Center, Albert Einstein College of Medicine/Montefiore Medical Center; Montefiore Einstein Cancer Center, Albert Einstein College of Medicine/Montefiore Medical Center; Integrated Imaging Program for Cancer Research, Albert Einstein College of Medicine/Montefiore Medical Center; david.entenberg@einsteinmed.edu.
Albert Einstein College of Medicine · USMontefiore Medical Center · US

Funding

WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI STEVEN C. ALMO · 1985 to 2026
$111.2M
(7) Novel imaging devices for measurement and control of tumor microenvironmentsR01CA216248 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI CADY, NATHANIEL CHARLES, CONDEELIS, JOHN S · 2017 to 2021
$2.9M
THE EFFECT OF TUMOR MICROENVIRONMENT ON METASTASISR01CA255153 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI CONDEELIS, JOHN S, ENTENBERG, DAVID · 2021 to 2025
$2.5M
MicroPET/SPECT/CT animal imaging device for translational researchS10RR029545 · NCRR · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI FINE, EUGENE · 2010 to 2010
$1.4M
NCI NIH HHS P30 CA013330NCI NIH HHS R01 CA216248NCI NIH HHS R01 CA255153NCRR NIH HHS S10 RR029545Wellcome TrustWellcome Trust 221647/Z/20/Z
6 · The paper itself

Abstract

Metastasis - the systemic spread of cancer - is the leading cause of cancer-related deaths. Although metastasis is commonly thought of as a unidirectional process wherein cells from the primary tumor disseminate and seed metastases, tumor cells in existing metastases can also redisseminate and give rise to new lesions in tertiary sites in a process known as "metastasis-from-metastases" or "metastasis-to-metastasis seeding." Metastasis-to-metastasis seeding may increase the metastatic burden and decrease the patient's quality of life and survival. Therefore, understanding the processes behind this phenomenon is crucial to refining treatment strategies for patients with metastatic cancer. Little is known about metastasis-to-metastasis seeding, due in part to logistical and technological limitations. Studies on metastasis-to-metastasis seeding rely primarily on sequencing methods, which may not be practical for researchers studying the exact timing of metastasis-to-metastasis seeding events or what promotes or prevents them. This highlights the lack of methodologies that facilitate the study of metastasis-to-metastasis seeding. To address this, we have developed - and describe herein - a murine surgical protocol for the selective photoconversion of lung metastases, allowing specific marking and fate tracking of tumor cells redisseminating from the lung to tertiary sites. To our knowledge, this is the only method for studying tumor cell redissemination and metastasis-to-metastasis seeding from the lungs that does not require genomic analysis.

Indexed as

Lung NeoplasmsQuality of LifeAnimalsHumansMiceNeoplasm Metastasis

Identifiers

PMID37486129
PMCPMC10832329
OpenAlexW4383498081

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.